Effects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months

dc.contributor.authorAres, Susana
dc.contributor.authorSáenz-Rico de Santiago, María Belén
dc.contributor.authorArnáez, Juan
dc.contributor.authorDíez-Sebastián, Jesús
dc.contributor.authorOmeñaca, Félix
dc.contributor.authorBernal, Jorge
dc.date.accessioned2024-01-15T17:47:57Z
dc.date.available2024-01-15T17:47:57Z
dc.date.issued2021
dc.descriptionSusana Ares and Juan Arnaez: both doctors have conceptualized and designed the study, collected the samples, recruited the subjects, collected the data and drafted the initial manuscript and approved the final manuscript as submitted. Belen Saenz-Rico applied the neurodevelopmental tests and recorded all the scores, and psychopedagogical follow-up from the neonatal period to 24 months of management age. Jesus Diez carried out the initial and final statistical analyses. Felix Omeñaca and Juan Bernal conceptualized and designed the study, prepared the documents for the ethics committee, parents information sheet and critically reviewed and revised the manuscript. This study was conducted by an interdisciplinary research team due to the nature of the population with a high degree of comorbidities in the school-age group and the focus of the study
dc.description.abstractThe trace element iodine (I) is essential for the synthesis of thyroid hormones. Parenteral nutrition solutions, formula milk, and human breast milk contain insufficient iodine to meet recommended intake for preterm infants. Iodine defciency may affect thyroid function and may be associated with morbidity or neurological outcomes. The primary objective is to assess the evidence that dietary supplementation with iodine affects thyroid function during the neonatal period. The design was a randomised controlled pilot trial. Infants who met the inclusion criteria were enrolled through consecutive sampling and assigned to two diferent groups. The setting was a Spanish university hospital. Ninety-four patients with very low birth weight (under 1500 g) were included. Intervention group: 30 µg I/kg/day of iodine in oral drops given to 47 infants from their frst day of life until hospital discharge. Control group: 47 infants without supplements. Formula and maternal milk samples for the determination of iodine content were collected at 1, 7, 15, 21, 30 days, and at discharge. Blood samples were collected for thyroid hormones. Neurological development was assessed at 2 years of age (Bayley III Test). Infants in the supplemented group reached the recommended levels from the first days of life. The researchers detected the effects of iodine balance on the plasma levels of thyroid hormones measured during the first 12 weeks of age. The trial assessed the impact of the intervention on neurodevelopmental morbidity. The conclusion is that thyroid function is related to iodine intake in preterm infants. Therefore, supplements should be added if iodine intake is found to be inadequate. The analyses found no effects of iodine supplementation on the composite scores for BayleyIII assessments in all major domains. The study results indicate potentially important efects on language development related to low iodine excretion during the first 4 weeks of life.
dc.description.departmentDepto. de Estudios Educativos
dc.description.facultyFac. de Educación
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades (España)
dc.description.sponsorshipInstituto de Salud Carlos III
dc.description.statuspub
dc.identifier.citationAres, S., Saenz-Rico, B., Arnaez, J. et al. Effects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months. Eur J Pediatr 181, 959–972 (2022). https://doi.org/10.1007/s00431-021-04288-5
dc.identifier.doi10.1007/s00431-021-04288-5
dc.identifier.essn1432-1076
dc.identifier.issn0340-6199
dc.identifier.officialurlhttps://doi.org/10.1007/s00431-021-04288-5
dc.identifier.relatedurlhttps://digital.csic.es/handle/10261/295329
dc.identifier.urihttps://hdl.handle.net/20.500.14352/93202
dc.issue.number181
dc.journal.titleEuropean journal of pediatrics
dc.language.isoeng
dc.page.final972
dc.page.initial959
dc.publisherSpringer
dc.relation.projectIDGrant PI06/ 1310 to S.A. and PI03/1417 to G.M.E.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsrestricted access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.cdu616-053.32
dc.subject.cdu611.44
dc.subject.cdu612.65-053.2
dc.subject.cdu37.013
dc.subject.keywordHypothyroxinemia
dc.subject.keywordPreterm infants
dc.subject.keywordThyroid
dc.subject.keywordNeurodevelopment
dc.subject.keywordIodine deficiency
dc.subject.ucmCiencias Sociales
dc.subject.ucmEndocrinología
dc.subject.ucmMedicina
dc.subject.ucmDietética y nutrición (Farmacia)
dc.subject.ucmPedagogía
dc.subject.unesco32 Ciencias Médicas
dc.subject.unesco58 Pedagogía
dc.titleEffects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication36dec1f3-05fc-470a-b7d8-9b6ae434d820
relation.isAuthorOfPublication.latestForDiscovery36dec1f3-05fc-470a-b7d8-9b6ae434d820

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Effects_of_oral_iodine_supplementation.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format

Collections